Literature DB >> 10459928

Success with the DOTS strategy.

A Mushtaque1, R Chowdhury.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10459928     DOI: 10.1016/s0140-6736(99)02119-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Drug-resistant tuberculosis: what do we do now?

Authors:  A Telenti; M Iseman
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 2.  A classification and meta-analysis of community-based directly observed therapy programs for tuberculosis treatment in developing countries.

Authors:  Shreya Kangovi; Joia Mukherjee; Richard Bohmer; Garret Fitzmaurice
Journal:  J Community Health       Date:  2009-12

3.  Lay workers in directly observed treatment (DOT) programmes for tuberculosis in high burden settings: Should they be paid? A review of behavioural perspectives.

Authors:  Samson Kironde; Francis Bajunirwe
Journal:  Afr Health Sci       Date:  2002-08       Impact factor: 0.927

4.  Does directly observed therapy (DOT) reduce drug resistant tuberculosis?

Authors:  Patrick K Moonan; Teresa N Quitugua; Janice M Pogoda; Gary Woo; Gerry Drewyer; Behzad Sahbazian; Denise Dunbar; Kenneth C Jost; Charles Wallace; Stephen E Weis
Journal:  BMC Public Health       Date:  2011-01-07       Impact factor: 3.295

5.  Clinical characteristics and treatment outcomes of patients with low- and high-concentration isoniazid-monoresistant tuberculosis.

Authors:  Tsai-Yu Wang; Shu-Min Lin; Shian-Sen Shie; Pai-Chien Chou; Chien-Da Huang; Fu-Tsai Chung; Chih-His Kuo; Po-Jui Chang; Han-Pin Kuo
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.